Michael M Abecassis insider trades

Open-market stock purchases and sales by Michael M Abecassis, Director at PharmaCyte Biotech, Inc, from SEC Form 4 filings since Nov 20, 2023.

Recent trades

DateStockTradeValue
Mar 31, 2026PMCB PharmaCyte Biotech, IncBought (not open market)—
Mar 31, 2026PMCB PharmaCyte Biotech, IncBought (not open market)—
Dec 12, 2025PMCB PharmaCyte Biotech, IncSold (not open market)$17.2K
Dec 12, 2025PMCB PharmaCyte Biotech, IncBought (not open market)—

Companies traded

  • PMCB PharmaCyte Biotech, Inc: other filings, last Mar 31, 2026

Get free alerts when Michael M Abecassis files a new trade →